微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.25% | -81.2% | 101.27% | 113/158 | 2.28% | 百利天恒 | 186.1% | 行业排名> |
| 2023-12-31 | -19.65% | -4030% | -1427.7% | 134/158 | -1.48% | 百利天恒 | 186.89% | 行业排名> |
| 2023-09-30 | 1.48% | -37.29% | 14.73% | 107/158 | 2.41% | 百利天恒 | 188.56% | 行业排名> |
| 2023-06-30 | 1.29% | -12.24% | -3.01% | 97/158 | 1.49% | 小方制药 | 41.8% | 行业排名> |
| 2023-03-31 | 1.33% | -2.92% | 166% | 78/158 | 1.38% | 拓新药业 | 20.51% | 行业排名> |
| 2022-12-31 | 0.5% | 103.96% | -78.81% | 105/158 | 0.38% | 拓新药业 | 19.87% | 行业排名> |
| 2022-09-30 | 2.36% | -60.6% | 60.54% | 92/158 | 2.89% | 拓新药业 | 19.91% | 行业排名> |
| 2022-06-30 | 1.47% | -42.8% | 7.3% | 96/158 | 2.03% | 小方制药 | 55.57% | 行业排名> |
| 2022-03-31 | 1.37% | -18.93% | 110.86% | 76/158 | 1.61% | 福元医药 | 25.41% | 行业排名> |
| 2021-12-31 | -12.62% | -512.42% | -310.68% | 132/158 | 0.29% | 小方制药 | 34.81% | 行业排名> |
| 2021-09-30 | 5.99% | 11.34% | 133.07% | 67/158 | 4.53% | 退市金泰 | 10.74% | 行业排名> |
| 2021-06-30 | 2.57% | 18.43% | 52.07% | 87/158 | 2.98% | 人福医药 | 6.82% | 行业排名> |
| 2021-03-31 | 1.69% | 16.55% | -44.77% | 75/158 | 2.5% | 小方制药 | 71.99% | 行业排名> |
| 2020-12-31 | 3.06% | 124.56% | -43.12% | 96/158 | 3.68% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-09-30 | 5.38% | 14.47% | 147.93% | 69/158 | 3.24% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 2.17% | -12.85% | 49.66% | 85/158 | 4.23% | 哈三联 | 27.17% | 行业排名> |
| 2020-03-31 | 1.45% | -3.33% | 111.64% | 61/158 | 2.23% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | -12.46% | -319.37% | -365.11% | 126/158 | 2.65% | 河化股份 | 45.32% | 行业排名> |
| 2019-09-30 | 4.7% | -10.82% | 88.76% | 70/158 | 7.62% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 2.49% | -21.2% | 66% | 79/158 | 5.05% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-03-31 | 1.5% | 2.04% | -73.59% | 71/158 | 2.47% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 5.68% | 1.25% | 7.78% | 81/158 | 7.1% | 奥赛康 | 28.15% | 行业排名> |
| 2018-09-30 | 5.27% | 10.25% | 66.77% | 66/158 | 7.22% | 宏源药业 | 21.91% | 行业排名> |
| 2018-06-30 | 3.16% | 7.48% | 114.97% | 65/158 | 4.6% | 奥赛康 | 9.7% | 行业排名> |
| 2018-03-31 | 1.47% | 11.36% | -73.8% | 69/158 | 2.57% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 5.61% | 110.11% | 17.36% | 80/158 | 9.58% | 信立泰 | 25.93% | 行业排名> |
| 2017-09-30 | 4.78% | 3.69% | 62.59% | 66/158 | 8.27% | 昂利康 | 15.91% | 行业排名> |
| 2017-06-30 | 2.94% | 80.37% | 122.73% | 72/158 | 5.58% | 奥赛康 | 12.08% | 行业排名> |
| 2017-03-31 | 1.32% | 169.39% | -50.56% | 59/158 | 2.09% | 一品红 | 31.62% | 行业排名> |
| 2016-12-31 | 2.67% | -43.19% | -42.08% | 95/158 | 7.15% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-09-30 | 4.61% | 5.73% | 182.82% | 54/158 | 5.6% | 河化股份 | 54.24% | 行业排名> |
| 2016-06-30 | 1.63% | -16.84% | 232.65% | 74/158 | 3.84% | 华东医药 | 7.2% | 行业排名> |
| 2016-03-31 | 0.49% | -22.22% | -89.57% | 71/158 | 2.62% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 4.7% | -15.32% | 7.8% | 75/158 | 11.28% | 德展健康 | 29.5% | 行业排名> |
| 2015-09-30 | 4.36% | 7.65% | 122.45% | 52/158 | 7.19% | 贝达药业 | 16.78% | 行业排名> |
| 2015-06-30 | 1.96% | -19.67% | 211.11% | 58/158 | 4.86% | 河化股份 | 19.29% | 行业排名> |
| 2015-03-31 | 0.63% | -50% | -88.65% | 56/158 | 2.39% | 一品红 | 58.17% | 行业排名> |
| 2014-12-31 | 5.55% | -9.02% | 37.04% | 67/158 | 12.31% | 华东医药 | 36.97% | 行业排名> |
| 2014-09-30 | 4.05% | -22.26% | 65.98% | 43/158 | 7.49% | 华东医药 | 26.63% | 行业排名> |
| 2014-06-30 | 2.44% | -21.54% | 93.65% | 46/158 | -4.83% | 广生堂 | 15.57% | 行业排名> |
| 2014-03-31 | 1.26% | -33.68% | -79.34% | 46/158 | 2.12% | 退市金泰 | 97.4% | 行业排名> |